Announcements Trials
Browse Landscape

Phase

Phase NA 43Phase 2 4Phase 1 3Phase 3 1

Status

Completed 24Active not recruiting 11Terminated 8Withdrawn 7Recruiting 4Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2Gynecologic 1

Conditions

Oropharyngeal Neoplasms 2Uterine Cervical Neoplasms 1Pain 1Carcinoma 1Cancer Pain 1Arthralgia 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 198Cisplatin 188Magnetic Resonance Spectroscopy 168Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 118Paclitaxel 112Oxaliplatin 110Biopsy 107venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 70sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Surveys and Questionnaires × Clear all
NCT05541016 2026-05-12

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Mayo Clinic

Phase 2 Recruiting
455 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

NCT06984861 2026-05-11

A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
74 enrolled
Head & Neck

Oropharyngeal Neoplasms

NCT06728579 2026-04-17

Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
200 enrolled

Cancer Pain, Pain, Arthralgia

NCT07276360 2026-03-27

HypoRTCx-UG

Uganda Cancer Institute

Phase 2 Recruiting
278 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡